| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 9.134 | 0 | 56.873 | 65.537 | 53.090 | 89.988 | 93.362 | 121.328 | 122.575 |
| Total Income - EUR | - | 9.134 | 0 | 56.875 | 65.539 | 53.090 | 89.994 | 93.367 | 121.332 | 122.582 |
| Total Expenses - EUR | - | 7.777 | 0 | 27.487 | 32.356 | 33.219 | 42.914 | 34.079 | 46.309 | 57.596 |
| Gross Profit/Loss - EUR | - | 1.357 | 0 | 29.387 | 33.183 | 19.871 | 47.080 | 59.288 | 75.023 | 64.986 |
| Net Profit/Loss - EUR | - | 1.266 | 0 | 28.819 | 32.528 | 19.546 | 46.261 | 58.373 | 73.992 | 61.860 |
| Employees | - | 3 | 0 | 3 | 3 | 3 | 3 | 3 | 3 | 2 |
Check the financial reports for the company - Criscodanmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 112 | 0 | 1.043 | 819 | 554 | 1.444 | 1.000 | 549 | 718 |
| Current Assets | - | 2.323 | 0 | 50.810 | 51.844 | 73.787 | 103.637 | 116.911 | 168.057 | 158.083 |
| Inventories | - | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 282 | 0 |
| Receivables | - | 1.459 | 0 | 45.177 | 30.301 | 53.431 | 88.216 | 107.569 | 115.100 | 92.493 |
| Cash | - | 865 | 0 | 5.633 | 21.543 | 20.348 | 15.421 | 9.342 | 52.675 | 65.591 |
| Shareholders Funds | - | 1.310 | 0 | 44.872 | 32.572 | 19.589 | 103.660 | 104.958 | 132.134 | 135.479 |
| Social Capital | - | 45 | 0 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.125 | 0 | 6.981 | 20.091 | 54.751 | 1.422 | 12.952 | 36.472 | 23.322 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Criscodanmed Srl